Pharmaceutical Executive
The importance of betting on outcomes, not simply risk sharing, when implementing pharma-payer arrangements. .
Urs Wiedemann
Advertisement
Articles by Urs Wiedemann
Advertisement
Latest Updated Articles
Raising the Stakes On Value-Based PricingApril 12th 2016
Advertisement
Advertisement
Trending on PharmExec
1
The Impact That the Renewed Focus on Domestic Manufacturing Might Have on the Supply Chain
2
AstraZeneca Taps insitro AI for MASH in Deal Worth Up to $1.5 Billion
3
FDA Launches Rare Disease Framework Initiative
4
Pharmaceutical Executive Daily: Gilead Enters $1.87 Billion Collaboration and License Agreement with Vir Biotechnology
5